Osaic Holdings’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100
Closed -$2K 7111
2020
Q4
$2K Hold
100
﹤0.01% 6152
2020
Q3
$2K Hold
100
﹤0.01% 5943
2020
Q2
$1K Hold
100
﹤0.01% 6052
2020
Q1
$2K Buy
+100
New +$1.62K ﹤0.01% 5768

Osaic Holdings's CBMG Position: Q1 2021 in Review

Osaic Holdings sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 100 shares — an estimated $2K sold.

Osaic Holdings first reported a position in CBMG in Q1 2020 and held it in 4 quarters. The position peaked at $2K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Osaic Holdings reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Osaic Holdings sold 100 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $2K.
  • Osaic Holdings first reported a position in Cellular Biomedicine Group, Inc. in Q1 2020 and held it in 4 quarters.
  • Osaic Holdings's Cellular Biomedicine Group, Inc. position peaked at $2K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Osaic Holdings's 13F filing for Q1 2021, filed 13 May 2021.